ophtalmic

BRIEF: Cloudbreak tumbles in Hong Kong trading debut

Ophthalmic biotech company Cloudbreak Pharma Inc. (2592.HK) opened down 6% in its Hong Kong trading debut on Wednesday, and continued to fall during the morning session to close down 30% at HK$7.04…
2592.HK

Recent Articles

RELATED ARTICLES

  1. BRIEF: Cloudbreak launches $78 million Hong Kong IPO
    2592.HK
  2. After a failed Fosun buyout, what’s next for drug maker Henlius Biotech?
    2696.HK
  3. BRIEF: MetaLight tumbles in Hong Kong trading debut
    2605.HK
  4. BRIEF: CaoCao tumbles in Hong Kong trading debut
    2643.HK
  5. BRIEF: Duality Biotherapies surges in Hong Kong trading debut
    9606.HK
  6. BRIEF: Saimo Technology ticks up in Hong Kong trading debut
    2571.HK
  7. BRIEF: Numans sinks in Hong Kong trading debut
    2530.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva